Trial Profile
Assessment of Coronary Plaque Composition Using Near Infrared Spectroscopy During Inhibition of Lipoprotein-associated Phospholipase A2 (Lp-PLA2) Activity
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Darapladib (Primary)
- Indications Coronary artery disease
- Focus Pharmacodynamics
- 22 Apr 2017 New trial record